blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2872131

EP2872131 - OLEACEIN FOR TREATING OR PREVENTING DISEASES RESULTING FROM ATHEROSCLEROTIC PLAQUES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.09.2019
Database last updated on 03.09.2024
FormerThe patent has been granted
Status updated on  19.10.2018
FormerGrant of patent is intended
Status updated on  16.09.2018
FormerExamination is in progress
Status updated on  17.08.2018
FormerGrant of patent is intended
Status updated on  02.04.2018
FormerExamination is in progress
Status updated on  10.02.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Warszawski Uniwersytet Medyczny
Ul. Zwirki i Wigury 61
02-091 Warszawa / PL
[2015/21]
Inventor(s)01 / CZERWINSKA, Monika, Ewa
ul. Leszczynowa 9A
05-120 Legionowo / PL
02 / KISS, Anna, Karolina
ul. J. Dabrowskiego 13/1
02-558 Warszawa / PL
03 / NARUSZEWICZ, Marek, Aleksy
ul. Zaczarowanej Rózy 12
05-540 Zalesie Górne / PL
04 / FILIPEK, Agnieszka
ul. Nadarzynska 5B
Zólwin
05-807 Podkowa Lesna / PL
 [2015/21]
Representative(s)Witek, Rafal
WTS Patent Attorneys
Witek, Sniezko & Partners
ul. Weigla 12
53-114 Wroclaw / PL
[2018/47]
Former [2015/21]Witek, Rafal
WTS Patent Attorneys
Witek, Sniezko & Partners
ul. Rudolfa Weigla 12
53-114 Wroclaw / PL
Application number, filing date13742600.313.07.2013
[2018/47]
WO2013EP64869
Priority number, datePL2012039996214.07.2012         Original published format: PL 39996212
[2015/21]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014012871
Date:23.01.2014
Language:EN
[2014/04]
Type: A1 Application with search report 
No.:EP2872131
Date:20.05.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 23.01.2014 takes the place of the publication of the European patent application.
[2015/21]
Type: B1 Patent specification 
No.:EP2872131
Date:21.11.2018
Language:EN
[2018/47]
Search report(s)International search report - published on:EP23.01.2014
ClassificationIPC:A61K36/638, A61K31/222, A61P9/10
[2018/16]
CPC:
A61K31/222 (EP,US); A61P9/04 (EP); A61P9/10 (EP);
A61K31/19 (US); A61K36/638 (US)
Former IPC [2015/21]A61K31/222, A61P9/10
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/21]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:OLEACEIN ZUR BEHANDLUNG ODER PRÄVENTION VON AUS ATHEROSKLEROTISCHEN PLAQUES RESULTIERENDEN KRANKHEITEN[2018/16]
English:OLEACEIN FOR TREATING OR PREVENTING DISEASES RESULTING FROM ATHEROSCLEROTIC PLAQUES[2015/21]
French:OLÉACÉINE DESTINÉE AU TRAITEMENT OU À LA PRÉVENTION DE MALADIES RÉSULTANT DE PLAQUES D'ATHÉROSCLÉROSE[2015/21]
Former [2015/21]OLEACEIN ZUR BEHANDLUNG ODER PRÄVENTION VON ATHEROSKLEROTISCHEN PLAQUES
Entry into regional phase16.02.2015National basic fee paid 
16.02.2015Designation fee(s) paid 
16.02.2015Examination fee paid 
Examination procedure16.02.2015Examination requested  [2015/21]
21.09.2015Amendment by applicant (claims and/or description)
25.07.2016Despatch of a communication from the examining division (Time limit: M06)
03.02.2017Reply to a communication from the examining division
12.03.2018Cancellation of oral proceeding that was planned for 26.03.2018
26.03.2018Date of oral proceedings (cancelled)
03.04.2018Communication of intention to grant the patent
06.08.2018Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
13.08.2018Fee for grant paid
13.08.2018Fee for publishing/printing paid
17.09.2018Communication of intention to grant the patent
11.10.2018Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  25.07.2016
Opposition(s)22.08.2019No opposition filed within time limit [2019/44]
Fees paidRenewal fee
31.07.2015Renewal fee patent year 03
01.08.2016Renewal fee patent year 04
31.07.2017Renewal fee patent year 05
31.07.2018Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU13.07.2013
AL21.11.2018
AT21.11.2018
CY21.11.2018
CZ21.11.2018
EE21.11.2018
HR21.11.2018
LT21.11.2018
LV21.11.2018
MC21.11.2018
MK21.11.2018
MT21.11.2018
RO21.11.2018
RS21.11.2018
SI21.11.2018
SK21.11.2018
SM21.11.2018
TR21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
LU13.07.2019
[2022/31]
Former [2021/34]HU13.07.2013
AL21.11.2018
AT21.11.2018
CY21.11.2018
CZ21.11.2018
EE21.11.2018
HR21.11.2018
LT21.11.2018
LV21.11.2018
MC21.11.2018
MT21.11.2018
RO21.11.2018
RS21.11.2018
SI21.11.2018
SK21.11.2018
SM21.11.2018
TR21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
LU13.07.2019
Former [2021/32]HU13.07.2013
AL21.11.2018
AT21.11.2018
CY21.11.2018
CZ21.11.2018
EE21.11.2018
HR21.11.2018
LT21.11.2018
LV21.11.2018
MC21.11.2018
RO21.11.2018
RS21.11.2018
SI21.11.2018
SK21.11.2018
SM21.11.2018
TR21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
LU13.07.2019
Former [2021/26]AL21.11.2018
AT21.11.2018
CY21.11.2018
CZ21.11.2018
EE21.11.2018
HR21.11.2018
LT21.11.2018
LV21.11.2018
MC21.11.2018
RO21.11.2018
RS21.11.2018
SI21.11.2018
SK21.11.2018
SM21.11.2018
TR21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
LU13.07.2019
Former [2020/27]AL21.11.2018
AT21.11.2018
CZ21.11.2018
EE21.11.2018
HR21.11.2018
LT21.11.2018
LV21.11.2018
MC21.11.2018
RO21.11.2018
RS21.11.2018
SI21.11.2018
SK21.11.2018
SM21.11.2018
TR21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
LU13.07.2019
Former [2020/17]AL21.11.2018
AT21.11.2018
CZ21.11.2018
EE21.11.2018
HR21.11.2018
LT21.11.2018
LV21.11.2018
MC21.11.2018
RO21.11.2018
RS21.11.2018
SI21.11.2018
SK21.11.2018
SM21.11.2018
TR21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
Former [2020/14]AL21.11.2018
AT21.11.2018
CZ21.11.2018
EE21.11.2018
HR21.11.2018
LT21.11.2018
LV21.11.2018
MC21.11.2018
RO21.11.2018
RS21.11.2018
SI21.11.2018
SK21.11.2018
SM21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
Former [2019/50]AL21.11.2018
AT21.11.2018
CZ21.11.2018
EE21.11.2018
HR21.11.2018
LT21.11.2018
LV21.11.2018
RO21.11.2018
RS21.11.2018
SI21.11.2018
SK21.11.2018
SM21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
Former [2019/40]AL21.11.2018
AT21.11.2018
CZ21.11.2018
EE21.11.2018
HR21.11.2018
LT21.11.2018
LV21.11.2018
RO21.11.2018
RS21.11.2018
SK21.11.2018
SM21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
Former [2019/37]AL21.11.2018
AT21.11.2018
CZ21.11.2018
EE21.11.2018
HR21.11.2018
LT21.11.2018
LV21.11.2018
RO21.11.2018
RS21.11.2018
SM21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
Former [2019/35]AL21.11.2018
AT21.11.2018
CZ21.11.2018
HR21.11.2018
LT21.11.2018
LV21.11.2018
RS21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
Former [2019/26]AL21.11.2018
AT21.11.2018
HR21.11.2018
LT21.11.2018
LV21.11.2018
RS21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
Former [2019/25]AT21.11.2018
HR21.11.2018
LT21.11.2018
LV21.11.2018
RS21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
Former [2019/24]AT21.11.2018
HR21.11.2018
LT21.11.2018
LV21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
Former [2019/23]AT21.11.2018
HR21.11.2018
LT21.11.2018
LV21.11.2018
BG21.02.2019
NO21.02.2019
IS21.03.2019
Former [2019/22]LT21.11.2018
BG21.02.2019
NO21.02.2019
IS21.03.2019
Former [2019/21]LT21.11.2018
NO21.02.2019
IS21.03.2019
Former [2019/20]LT21.11.2018
NO21.02.2019
Cited inInternational search[XY]WO2009013596  (PROBELTE PHARMA S A [ES], et al) [X] 1-5 * claim 1 * * example 12 * [Y] 6;
 [XY]  - M. Czerwinska ET AL, "OLEACEIN FROM VIRGIN OLIVE OIL MAY CONTRIBUTES TO STABILIZATION OF ATHEROSCLEROTIC PLAQUES BY DECREASE MYELOPEROXIDASE RELEASE FROM NEUTROPHILS", EAS2012 abstract book, (20120529), page 1108, URL: http://www.kenes.com/eas2012/abstracts/pdf/1108.pdf, (20130826), XP055076427 [X] 1-5 * the whole document * [Y] 6
 [IY]  - MONIKA CZERWISKA ET AL, "A comparison of antioxidant activities of oleuropein and its dialdehydic derivative from olive oil, oleacein", FOOD CHEMISTRY, ELSEVIER LTD, NL, vol. 131, no. 3, doi:10.1016/J.FOODCHEM.2011.09.082, ISSN 0308-8146, (20110920), pages 940 - 947, (20110928), XP028104623 [I] 1-5 * abstract * * page 945, paragraph 1 - column 2 * * page 946, column 2, paragraph 4 * [Y] 6

DOI:   http://dx.doi.org/10.1016/j.foodchem.2011.09.082
 [YD]  - KISS ET AL., JOURNAL OF ETHNOPHARMACOLOGY, (2008), vol. 120, pages 220 - 225, XP025669784 [YD] 6 * abstract * * table 1 * * figure 1 *

DOI:   http://dx.doi.org/10.1016/j.jep.2008.08.015
by applicant   - FATAR M; STROICK M; GRIEBE M; HENNERICI M, "Matrix metalloproteinases in cerebrovascular diseases", CEREBROVASC DIS, (2005), vol. 20, pages 141 - 51
    - KISS ET AL., JOURNAL OF ETHNOPHARMACOLOGY, (2008), vol. 120, pages 220 - 225
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.